Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction

Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction

Background Hypertrophic cardiomyopathy (HCM) is characterised by abnormal thickening of ventricular myocardium. Left ventricular outflow tract (LVOT) obstruction occurs in up to 70% of patients, causing progressive symptoms, heart failure and mortality. Mavacamten, the first targeted therapy for obs...

Full description

Saved in:
Bibliographic Details
Main Authors: Jane Draper, Antonio De Marvao, Robert M Cooper, Gerry Carr-White, Nabeel Sheikh, Rachel Bastiaenen, Yande Kasolo, Jason N Dungu, Edward Burford
Format: Article
Language:English
Published: BMJ Publishing Group 2025-04-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/12/1/e003218.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://openheart.bmj.com/content/12/1/e003218.full

Similar Items